Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease

Launched by POITIERS UNIVERSITY HOSPITAL · Jul 31, 2023

Keywords

ClinConnect Summary

This clinical trial is looking into the characteristics of patients who have invasive meningococcal disease, which is a serious infection caused by a bacteria called Neisseria meningitidis. Recently, there has been an unusual rise in cases of this infection, especially between late 2022 and early 2023. Many of these cases are different from what doctors typically see, as they often involve severe infections in the bloodstream without the more common symptoms of meningitis. The researchers want to understand why this is happening, especially after the COVID-19 pandemic, which may have changed how infections spread and how our bodies respond to them.

If you or a family member has been diagnosed with invasive meningococcal infection, you might be eligible to participate in this study. There are no specific age or gender restrictions, and anyone diagnosed with this infection, confirmed by tests from blood or other normally sterile sites, can join. Participants in the trial will help researchers learn more about this condition and potentially contribute to improving treatment and prevention strategies. Your involvement could be very valuable in understanding these unusual patterns of infection.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of Invasive Meningococcal infection (defined by the isolation of Neisseria meningitis in a normaly steril site (CSL, blood, articulation, ..) by PCR or culture.
• • No exclusion Criteria